Morgan Stanley's New Bitcoin ETF Just Pulled a Fast One on BlackRock (And Everyone Else)

Morgan Stanley dropped MSBT, the first spot Bitcoin ETF from a major U.S. bank, and it hit the ground running. We're talking the lowest fee in the game at 0.14%, the biggest Day 1 in Morgan Stanley's entire ETF history, and assets under management that roughly doubled in the first week. Rival issuers should be paying attention because this combo of cheapest fees plus a captive advisor network worth trillions is a problem. Actually, "problem" might be underselling it—this is the crypto ETF equivalent of showing up to a gunfight with a tank and also having the only gas station.

So how's it performing? MSBT started trading on NYSE Arca on April 8 with an April 7 inception date. It tracks the CoinDesk Bitcoin Benchmark Rate Index, holds real BTC with Coinbase as the crypto custodian and BNY Mellon handling cash and administration, and is structured as an ETP. Day 1 brought in roughly $30.6 million to $34 million in net inflows on more than 1.6 million shares traded. Bloomberg analyst Eric Balchunas placed it in the top 1% of all ETF debuts in history and called it "arguably the biggest Bitcoin ETF launch since they began." By April 13, cumulative net inflows since inception had climbed to $37.50 million, with another $6.28 million added that day alone. What's notable is that the broader spot Bitcoin ETF category saw net outflows the same day. Money was leaving rivals and still flowing into MSBT. That's not just winning—that's winning while your opponents are literally paying people to leave.

The fund's AUM sits around $63.84 million on Morgan Stanley's own numbers, with SoSoValue showing $70.12 million. It holds roughly 960 BTC. Market price closed at $21.05 against a $20.93 NAV, a modest 0.57% premium. Since-inception returns are tracking Bitcoin closely, with the market price up 6.86% and NAV up 6.24%. It's still small. MSBT ranks around #12 by AUM in a category now sitting near $94 billion, with BlackRock's IBIT still the undisputed leader. But the trajectory matters more than the starting point. Right now MSBT is basically a baby giraffe learning to walk, but giraffes grow up fast and also have zero natural predators. Just saying.

Why the 0.14% fee matters: MSBT's expense ratio undercuts every competitor in the U.S. spot Bitcoin ETF market. Morgan Stanley MSBT: 0.14%. BlackRock IBIT: 0.25%. Most others: 0.20% to 0.39%. Grayscale GBTC: historically the highest, still above the pack. Eleven basis points under IBIT sounds small. In ETF land it isn't. Fee compression is how BlackRock crushed Grayscale's GBTC lead in 2024, and Morgan Stanley is now running the same play on BlackRock. The difference this time is distribution. Morgan Stanley has around 16,000 financial advisors and more than $9 trillion in client assets sitting on its wealth platform. Balchunas and other analysts have floated $5 billion in AUM within the first year as a realistic target, built on that advisor pipeline alone. BlackRock has the brand. Morgan Stanley has the captive audience and a price advantage. This is basically bringing a knife to a gunfight but also having the only car in the parking lot.

Here's where it gets interesting for IBIT and the rest. Advisors and RIAs already on Morgan Stanley's platform now have a cheaper, in-house option sitting next to the ETFs they previously recommended. A fiduciary argument almost writes itself: same exposure, lower cost, same roof. Expect a slow bleed of reallocations as quarterly reviews hit. That's the vampire fund dynamic. MSBT doesn't need to pull capital off the street to grow. It can feed on its own ecosystem. The April 13 flow data is the early tell. On a day the category bled, MSBT absorbed $6.28 million. Whether that's redirected money from IBIT, Fidelity's FBTC, or fresh capital is impossible to say from the SoSoValue snapshot alone, but the direction is the point. When you're the only one drinking in a room full of people suddenly discovering they're thirsty, you tend to do well.

Three things are worth tracking over the next one to three months. First, weekly inflow rankings. If MSBT consistently shows up in the top three despite being the smallest in the top tier, the migration thesis is real. Second, IBIT's flow data. Any sustained slowdown there while MSBT climbs would be the clearest signal. Third, Morgan Stanley's advisor guidance. If internal desk research starts leaning on the fee comparison, the floodgates open faster. MSBT isn't going to topple IBIT in 2026. BlackRock's lead is measured in tens of billions. But the fee and distribution combo makes Morgan Stanley the first genuinely structural threat the incumbent spot Bitcoin ETFs have faced since the category launched. That's the real story of Day 1, and it's why this one is worth watching. This isn't a moonshot play—it's a slow-motion carve-out, and if you're holding IBIT or any of the other legacy spot ETFs, you should probably start side-eyeing your allocation strategy like someone who just noticed the snack table moved.